[1] |
McCluggage WG, Vosmikova H, Laco J. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma[J]. Int J Gynecol Pathol, 2020, 39(1):84-92. doi: 10.1097/PGP.0000000000000573.
doi: 10.1097/PGP.0000000000000573
pmid: 30575604
|
[2] |
Chapel DB, Joseph NM, Krausz T, et al. An Ovarian Adenocarcinoma With Combined Low-grade Serous and Mesonephric Morphologies Suggests a Müllerian Origin for Some Mesonephric Carcinomas[J]. Int J Gynecol Pathol, 2018, 37(5):448-459. doi: 10.1097/PGP.0000000000000444.
doi: 10.1097/PGP.0000000000000444
pmid: 28863071
|
[3] |
Mirkovic J, McFarland M, Garcia E, et al. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract[J]. Am J Surg Pathol, 2018, 42(2):227-233. doi: 10.1097/PAS.0000000000000958.
doi: 10.1097/PAS.0000000000000958
pmid: 28984674
|
[4] |
伍丽, 黄健容, 兰易, 等. CEA、CA199和CA125单独和联合应用在卵巢癌诊断中的效能分析[J]. 中国妇产科临床杂志, 2020, 21(1):56-57. doi: 10.13390/j.issn.1672-1861.2020.01.018.
doi: 10.13390/j.issn.1672-1861.2020.01.018
|
[5] |
McFarland M, Quick CM, McCluggage WG. Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas[J]. Histopathology, 2016, 68(7):1013-1020. doi: 10.1111/his.12895.
doi: 10.1111/his.12895
pmid: 26484981
|
[6] |
Kezlarian B, Muller S, Werneck Krauss Silva V, et al. Cytologic features of upper gynecologic tract adenocarcinomas exhibiting mesonephric-like differentiation[J]. Cancer Cytopathol, 2019, 127(8):521-528. doi: 10.1002/cncy.22160.
doi: 10.1002/cncy.22160
pmid: 31318491
|
[7] |
Euscher ED, Bassett R, Duose DY, et al. Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior[J]. Am J Surg Pathol, 2020, 44(4):429-443. doi: 10.1097/PAS.0000000000001401.
doi: 10.1097/PAS.0000000000001401
|
[8] |
Howitt BE, Emori MM, Drapkin R, et al. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract[J]. Am J Surg Pathol, 2015, 39(10):1411-1419. doi: 10.1097/PAS.0000000000000471.
doi: 10.1097/PAS.0000000000000471
|
[9] |
Kenny SL, McBride HA, Jamison J, et al. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β[J]. Am J Surg Pathol, 2012, 36(6):799-807. doi: 10.1097/PAS.0b013e31824a72c6.
doi: 10.1097/PAS.0b013e31824a72c6
|
[10] |
谢幸, 孔北华, 段涛. 妇产科学[M]. 9 版. 北京: 人民卫生出版社, 2018: 314.
|
[11] |
卢淮武, 许妙纯, 张钰豪, 等. 《2021 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南(第1版)》解读[J]. 中国实用妇科与产科杂志, 2021, 37(4):457-466. doi: 10.19538/j.fk2021040113.
doi: 10.19538/j.fk2021040113
|